NasdaqGS - Delayed Quote USD
Spyre Therapeutics, Inc. (SYRE)
17.29
-0.42
(-2.37%)
At close: June 13 at 4:00:00 PM EDT
17.29
0.00
(0.00%)
After hours: June 13 at 5:50:41 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 5.26M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ALBERS JEFFREY W Director | Sale at price 36.76 per share. | Indirect | 246,313 | Nov 6, 2024 |
| ALBERS JEFFREY W Director | Sale at price 36.43 per share. | Indirect | 10,929 | Oct 25, 2024 |
| BURROWS SCOTT L. Chief Financial Officer | Sale at price 28.17 per share. | Direct | 522,074 | Sep 3, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Apr 25, 2024 |
| TURTLE CAMERON Chief Executive Officer | Stock Award(Grant) at price 22.56 per share. | Direct | 9,024 | Feb 15, 2024 |
| BURROWS SCOTT L. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 22, 2023 |
| ALBERS JEFFREY W Director | -- | Indirect | -- | Nov 24, 2023 |
| TURTLE CAMERON Chief Executive Officer | -- | Direct | -- | Nov 24, 2023 |
| FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 24, 2023 |
Related Tickers
DNTH Dianthus Therapeutics, Inc.
18.31
-5.08%
ELVN Enliven Therapeutics, Inc.
21.91
+11.44%
CNTA Centessa Pharmaceuticals plc
12.38
+2.82%
APGE Apogee Therapeutics, Inc.
44.48
+6.26%
JBIO Jade Biosciences, Inc.
6.76
-2.59%
ORKA Oruka Therapeutics, Inc.
12.56
-2.41%
COGT Cogent Biosciences, Inc.
7.08
-1.94%
PHVS Pharvaris N.V.
16.70
-3.08%
XNCR Xencor, Inc.
9.19
-2.55%
TYRA Tyra Biosciences, Inc.
10.43
+0.97%